A multicenter retrospective cohort study across the Yale-New Haven Health System found that embedding a 2-part electronic health record–based care pathway for patients hospitalized with chronic obstructive...
In a large retrospective study, semaglutide users undergoing posterior cervical fusion had higher risks of pseudoarthrosis and dysphagia at 2 years. However, perioperative costs were significantly lower...
In the ADAPT-Sepsis trial, a daily procalcitonin-guided protocol significantly reduced antibiotic duration in critically ill adults with suspected sepsis without increasing mortality. In contrast, a...
From pandemics to natural disasters, clinicians share how value-based care models have enabled continuity, flexibility, and quality care when it’s needed most.
Explore how value-based care providers can navigate the clinical and financial impact of emerging therapies, biosimilars, and federal drug pricing reforms.
At the America’s Physician Groups Spring Conference 2025, clinical and policy leaders shared real-world insights on how physician organizations and payers are collaborating to improve outcomes, lower costs,...
Whether in the form of unnecessary tests, inappropriate referrals, or overuse of costly treatments, waste continues to erode value, strain resources, and impede patient-centered care.
With three FDA-approved treatments now available, clinicians must learn to spot the early signs and understand the evolving science behind hidradenitis suppurativa (HS), a painful and stigmatizing disease....
As surgical care evolves with the integration of risk calculators and biomarker-driven algorithms, it's tempting to rely heavily on these tools for clinical decisions. Yet, some elements of patient...
Despite unchanged treatment modalities for over 75 years, contemporary management of Graves’ disease increasingly centers on preserving thyroid function, with methimazole emerging as the preferred...
